To confirm the effect a knockdown of AGO2-ex1/3 has on melanoma cell growth and to rule out off-target effects, we designed a second siRNA targeting AGO2-ex1/3 which is shifted by a few nucleotides from the siAGO2-ex1/3. The gene discussed is AGO2; the disease is melanoma.